Does Oklahoma Medicaid cover Ozempic or Wegovy or Rybelsus for weight loss?

Not covered. Drugs used primarily for the treatment of obesity are not covered. Wegovy is not in the prior authorization category

Does Oklahoma Medicaid cover Mounjaro or Zepbound for weight loss?

Not covered. Drugs used primarily for the treatment of obesity are not covered. Zepbound is not in the prior authorization category

Does Oklahoma Medicaid cover Saxenda or Victoza for weight loss?

Not covered. Drugs used primarily for the treatment of obesity are not covered. Saxenda is not in the prior authorization category

Medicaid coverage

Oklahoma: what Medicaid covers

Oklahoma puts the exclusion in its administrative code rather than in a formulary: drugs used primarily for the treatment of obesity are not covered. SoonerCare’s 2026 prior authorization category for endocrine and diabetic agents matches that. Its GIP and GLP-1 table names only the diabetes products, Trulicity, Victoza, Ozempic, Rybelsus and Mounjaro, and the class criteria open by requiring an FDA approved diagnosis of type 2 diabetes.

Checked against the primary source August 28, 2026

What Medicaid in Oklahoma covers, and the criteria that apply.
Drug	Position	Criteria
Semaglutide	Not covered	Drugs used primarily for the treatment of obesity are not covered. Wegovy is not in the prior authorization category
Tirzepatide	Not covered	Drugs used primarily for the treatment of obesity are not covered. Zepbound is not in the prior authorization category
Liraglutide	Not covered	Drugs used primarily for the treatment of obesity are not covered. Saxenda is not in the prior authorization category

Semaglutide Not covered

Drugs used primarily for the treatment of obesity are not covered. Wegovy is not in the prior authorization category
Tirzepatide Not covered

Drugs used primarily for the treatment of obesity are not covered. Zepbound is not in the prior authorization category
Liraglutide Not covered

Drugs used primarily for the treatment of obesity are not covered. Saxenda is not in the prior authorization category

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

1
Oklahoma Administrative Code 317:30-5-72.1, Drug benefit
Oklahoma Health Care Authority (OHCA) Primary text read and checked Checked August 28, 2026
2
SoonerCare Prior Authorization 2026: Endocrine and Diabetic Agents
Oklahoma Health Care Authority (OHCA) Primary text read and checked Checked August 28, 2026